drugset / Trial / NCT06049017
A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety and effectiveness of JNJ-77242113 compared with placebo in participants with moderately to severely active ulcerative colitis.
Timeline
- Start
- 2023-10-09
- Primary completion
- 2024-09-26
- Completion
- 2026-01-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Icotrokinra | Peptide | — | Oral |